- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01476254
Respiratory Complications After Laparoscopic Surgery
Study Overview
Status
Detailed Description
The purpose of this study is to describe change in pulmonary function and incidence of respiratory complications after laparoscopic surgery.
The investigators will include 60 women scheduled for laparoscopic hysterectomy or cholecystectomy. The investigators will measure the pulmonary function by different methods during and for 2 hours after surgery. Moreover, the incidence of respiratory complications including pneumonia, respiratory failure and radiologically verified atelectasis will be registered.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Herlev, Denmark, 2730
- Department of Anesthesia, Herlev Hospital
-
Hillerød, Denmark, 3400
- Department of Anesthesia, Hillerød Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women
- > 45 years old
- Scheduled for laparoscopic cholecystectomy or laparoscopic hysterectomy
Exclusion Criteria:
- Weight < 50 kg
- Pregnant or nursing
- Cardiac failure
- Renal failure
- Inability to breath through a facial mask
- Inability to give informed consent
- Inability to keep arterial oxygen saturation above 90% without supplemental oxygen
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Cholecystectomy
Women scheduled for laparoscopic cholecystectomy
|
Hysterectomy
Women scheduled for laparoscopic hysterectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Arterial oxygen tension 2 hours after surgery
Time Frame: 2 hours after end of surgery
|
Change in arterial oxygen tension 2 hours after surgery
|
2 hours after end of surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxygenation index 2 hours after surgery
Time Frame: 2 hours after end of surgery
|
Change in oxygenation index (PaO2/FiO2) 2 hours after surgery
|
2 hours after end of surgery
|
FEV1 and FVC 2 hours after surgery
Time Frame: 2 hours after end of surgery
|
Change in FEV1 and FVC 2 hours after surgery
|
2 hours after end of surgery
|
Pulmonary shunt 2 hours after surgery
Time Frame: 2 hours after end of surgery
|
Change in pulmonary shunt 2 hours after surgery
|
2 hours after end of surgery
|
Ventilation-perfusion ratio 2 hours after surgery
Time Frame: 2 hours after end of surgery
|
Change in ventilation-perfusion ratio from baseline to 2 hours after surgery
|
2 hours after end of surgery
|
Arterial oxygen saturation 2 hours after surgery
Time Frame: 2 hours after surgery
|
Change in arterial oxygen saturation 2 hours after surgery
|
2 hours after surgery
|
Respiratory frequency 2 hours after surgery
Time Frame: 2 hours after surgery
|
Change in respiratory frequency 2 hours after surgery
|
2 hours after surgery
|
Oxygen supplement at discharge from the postanesthesia care unit
Time Frame: At discharge from the postanesthesia care unit, which will be approximately 2 hours after surgery
|
The proportion of patients who received oxygen supplement at discharge from the postanesthesia care unit in order keep arterial oxygen saturation above 93%
|
At discharge from the postanesthesia care unit, which will be approximately 2 hours after surgery
|
Connection between pulmonary shunt and need for oxygen supplement
Time Frame: 2 hours postoperatively and at discharge from the postanesthesia care unit
|
The connection between pulmonary shunt 2 hours after surgery and need for oxygen supplement at discharge from the postanesthesia department in order to keep peripheral oxygen saturation above 93%.
|
2 hours postoperatively and at discharge from the postanesthesia care unit
|
FEV1 and FVC 24 hours after surgery
Time Frame: 24 hours after surgery
|
Change in FEV1 and FVC 24 hours after surgery
|
24 hours after surgery
|
Pulmonary shunt 24 hours after surgery
Time Frame: 24 hours after surgery
|
Change in pulmonary shunt 24 hours after surgery
|
24 hours after surgery
|
Ventilation-perfusion ratio 24 hours after surgery
Time Frame: 24 hours after surgery
|
Change in ventilation-perfusion ratio 24 hours after surgery
|
24 hours after surgery
|
Arterial oxygen saturation 24 hours after surgery
Time Frame: 24 hours after surgery
|
Change in arterial oxygen saturation 24 hours after surgery
|
24 hours after surgery
|
Respiratory frequency 24 hours after surgery
Time Frame: 24 hours after surgery
|
Change in respiratory frequency 24 hours after surgery
|
24 hours after surgery
|
Length of stay
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Length of stay at the hospital
|
Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Pneumonia
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Incidence of pneumonia from surgery to discharge from hospital
|
Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Respiratory failure after surgery
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Incidence of respiratory failure from surgery to discharge from hospital
|
Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Atelectasis
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Incidence of radiologically verified atelectasis from surgery to discharge from hospital
|
Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
High temperature
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Incidence of a high temperature ( above 38 degrees celsius) from surgery to discharge from hospital
|
Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Mona R Gätke, M.D. Ph.D., Department of Anesthesia, Herlev Hospital, University of Copenhagen
- Principal Investigator: Anne K Staehr, M.D., Department of Anesthesia, Herlev Hospital, University of Copenhagen
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RESP-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityNot yet recruitingHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
-
Hu YinanEnrolling by invitationSialic Acid | Superoxide Dismutase | Lipid PneumoniaChina